Delivery Order SPE2DB24D2100-SPE2DB24FBAPZ
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, as the prime contractor. The award, valued at $9,385.29, is for the provision of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product, to support military treatment programs and facilities. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of FERAHEME, a specialty pharmaceutical product. The delivery order, valued at $5,988.60, is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order, valued at $3,388.30, is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product. The delivery order is a firm fixed price contract with a completion date of February 2, 2024. No set-aside designation was used for this...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $17,039.65 and is for the delivery of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a $3,162.71 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a specialty pharmaceutical product, with a period of performance through February 2, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,187.24 firm fixed-price contract is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a medical product, with a period of performance through February 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract, valued at $3,177.54, is for the delivery of 17 mL vials of the pharmaceutical product FERAHEME 510 MG/17 ML. The delivery order has a completion date of March 7, 2024 and was awarded on March 6, 2024. This contract is not designated as a set-aside. In addition...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,749.40, is for the delivery of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FERAHEME 510 MG/17 ML VIAL 17ML, a medical product, with a ceiling value of $17,575.71 and a period of performance ending on April 1, 2025. This is a firm fixed-price delivery order contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite...
- This is a $3,470.02 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4568318214 - FERAHEME 510 MG/17 ML VIAL 17ML. The contract has an ultimate completion date of May 22, 2025 and is not set aside. AmerisourceBergen Drug Corp is a critical supplier of pharmaceutical products and medical supplies to various federal agencies, particularly the military healthcare system,...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB24FBAPZDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $14,921.25, is for the provision of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product, with a period of performance through March 29, 2024. This delivery order is placed against an indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp as a single award, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.9k | 3/28/24 |